[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health":3,"$f3h1j55vnvythr":14},{"ok":4,"db":5,"lastOrangeBookRun":6,"lastDrugsFdaRun":9,"lastAlertsRun":12,"stale":13},true,"ok",{"status":5,"startedAt":7,"finishedAt":8,"lastOkAt":8},"2026-10-26T06:44:32.239Z","2026-10-26T06:44:53.640Z",{"status":5,"startedAt":10,"finishedAt":11,"lastOkAt":11},"2026-10-26T06:45:02.648Z","2026-10-26T06:45:13.189Z",null,false,{"tradeName":15,"ingredient":16,"applicant":17,"applicantSlug":18,"applNos":19,"loe":12,"latestLoe":12,"basis":21,"carveOutPossible":13,"openStrengths":22,"headlineStrengths":22,"headlineFallback":13,"products":23,"patents":49,"exclusivities":50,"paragraphIv":51,"catalysts":53},"EXFORGE HCT","AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; VALSARTAN","NOVARTIS","novartis",[20],"022314","none",5,[24,33,37,41,45],{"key":25,"applNo":20,"productNo":26,"dosageForm":27,"route":28,"strength":29,"approvalDate":30,"rld":4,"teCode":31,"type":32,"loe":12,"basis":21,"carveOutPossible":13},"022314-001","001","TABLET","ORAL","EQ 5MG BASE;12.5MG;160MG","2009-04-30","AB","RX",{"key":34,"applNo":20,"productNo":35,"dosageForm":27,"route":28,"strength":36,"approvalDate":30,"rld":4,"teCode":31,"type":32,"loe":12,"basis":21,"carveOutPossible":13},"022314-002","002","EQ 5MG BASE;25MG;160MG",{"key":38,"applNo":20,"productNo":39,"dosageForm":27,"route":28,"strength":40,"approvalDate":30,"rld":4,"teCode":31,"type":32,"loe":12,"basis":21,"carveOutPossible":13},"022314-003","003","EQ 10MG BASE;12.5MG;160MG",{"key":42,"applNo":20,"productNo":43,"dosageForm":27,"route":28,"strength":44,"approvalDate":30,"rld":4,"teCode":31,"type":32,"loe":12,"basis":21,"carveOutPossible":13},"022314-004","004","EQ 10MG BASE;25MG;160MG",{"key":46,"applNo":20,"productNo":47,"dosageForm":27,"route":28,"strength":48,"approvalDate":30,"rld":4,"teCode":31,"type":32,"loe":12,"basis":21,"carveOutPossible":13},"022314-005","005","EQ 10MG BASE;25MG;320MG",[],[],{"asOf":12,"firstFiled":12,"entries":52},[],[]]